TURCHETTI, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 40.333
NA - Nord America 35.665
AS - Asia 19.788
SA - Sud America 3.519
AF - Africa 480
Continente sconosciuto - Info sul continente non disponibili 130
OC - Oceania 87
AN - Antartide 1
Totale 100.003
Nazione #
US - Stati Uniti d'America 34.050
NL - Olanda 15.142
SG - Singapore 7.194
IT - Italia 6.325
RU - Federazione Russa 5.437
CN - Cina 5.000
GB - Regno Unito 4.681
VN - Vietnam 2.838
BR - Brasile 2.812
DE - Germania 2.382
UA - Ucraina 1.996
DK - Danimarca 1.240
CA - Canada 1.205
HK - Hong Kong 1.136
KR - Corea 1.073
FR - Francia 873
BD - Bangladesh 675
SE - Svezia 480
IN - India 458
FI - Finlandia 408
IE - Irlanda 349
PL - Polonia 310
AR - Argentina 266
MX - Messico 242
ES - Italia 170
ZA - Sudafrica 170
TR - Turchia 166
ID - Indonesia 162
JP - Giappone 160
IQ - Iraq 151
EC - Ecuador 127
EU - Europa 126
IL - Israele 101
PK - Pakistan 89
AT - Austria 86
CO - Colombia 76
AU - Australia 75
PH - Filippine 75
VE - Venezuela 67
MA - Marocco 66
BE - Belgio 62
CH - Svizzera 62
MY - Malesia 60
SA - Arabia Saudita 60
UZ - Uzbekistan 59
LT - Lituania 56
CL - Cile 50
PE - Perù 46
PT - Portogallo 41
JO - Giordania 40
AE - Emirati Arabi Uniti 38
PY - Paraguay 38
EG - Egitto 36
JM - Giamaica 35
TN - Tunisia 34
KE - Kenya 32
TW - Taiwan 32
RO - Romania 30
TH - Thailandia 28
IR - Iran 25
AZ - Azerbaigian 24
BG - Bulgaria 23
AL - Albania 21
DO - Repubblica Dominicana 21
ET - Etiopia 21
NP - Nepal 21
DZ - Algeria 19
SK - Slovacchia (Repubblica Slovacca) 19
HN - Honduras 18
KZ - Kazakistan 18
CZ - Repubblica Ceca 17
SN - Senegal 17
CR - Costa Rica 16
GR - Grecia 16
UY - Uruguay 16
HU - Ungheria 15
TT - Trinidad e Tobago 15
NG - Nigeria 14
NI - Nicaragua 14
RS - Serbia 14
BO - Bolivia 13
CI - Costa d'Avorio 13
CY - Cipro 13
HR - Croazia 13
ML - Mali 13
LV - Lettonia 12
OM - Oman 12
PA - Panama 12
BA - Bosnia-Erzegovina 11
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
AO - Angola 10
LB - Libano 10
GE - Georgia 8
GT - Guatemala 8
MD - Moldavia 8
SI - Slovenia 8
BY - Bielorussia 7
GH - Ghana 7
KG - Kirghizistan 7
Totale 99.869
Città #
Amsterdam 14.944
Dallas 6.213
Singapore 3.763
Southend 3.055
Ashburn 2.330
San Jose 2.197
Beijing 2.115
Chandler 2.063
Woodbridge 1.736
Houston 1.573
Ann Arbor 1.350
San Mateo 1.164
Hong Kong 1.090
Moscow 956
Milan 954
Jacksonville 947
Dearborn 840
Daejeon 815
Fairfield 780
The Dalles 761
Ho Chi Minh City 738
Falls Church 629
Rome 610
Cambridge 603
Los Angeles 595
Wilmington 575
Pisa 570
New York 527
Hanoi 487
Seattle 458
Hefei 408
Dong Ket 397
Lauterbourg 394
Stevenage 379
Boardman 371
Portsmouth 357
Montréal 339
Lawrence 325
Dublin 321
Santa Clara 319
São Paulo 311
Warsaw 267
Munich 264
Council Bluffs 254
Seoul 247
Buffalo 242
Brooklyn 234
Beauharnois 228
Fremont 191
Orem 186
Ottawa 177
Montreal 167
Redwood City 147
Figino 144
London 135
Denver 133
Old Bridge 130
Salerno 130
Chicago 129
Chennai 128
Tokyo 125
Atlanta 121
Mexico City 116
Stockholm 112
Florence 111
Johannesburg 111
Da Nang 104
Helsinki 102
San Diego 101
Poplar 100
Turin 98
Toronto 97
Mcallen 91
Phoenix 87
Frankfurt am Main 85
Bologna 84
Rio de Janeiro 84
Haiphong 82
Tel Aviv 77
San Francisco 75
Naples 74
Manchester 73
Nuremberg 71
Boston 64
Guangzhou 64
Ankara 62
Norwalk 59
Wuxi 57
Brasília 53
Serra 53
Tashkent 53
Biên Hòa 52
Belo Horizonte 50
Mumbai 50
Guayaquil 48
Shanghai 46
Baghdad 45
Paris 44
Charlotte 41
Palermo 41
Totale 65.955
Nome #
L’Economia digitale e il settore assicurativo 2.117
The interaction of public and private systems in healthcare provision 2.048
Il Costo Sociale della Malattia di Alzheimer 2.011
Il Costo Sociale dell’Emicrania 2.006
La qualità della vita di soggetti anziani nelle grandi città e nei piccoli paesi: uno studio comparato sui bisogni dei cittadini in Italia ed in Giappone 2.006
Il governo delle tecnologie per un ammodernamento del Sistema Sanitario 2.005
L’E-Commerce. Le Nuove Frontiere della Distribuzione Assicurativa 2.001
Prevenzione delle cadute da incidente domestico negli anziani 1.999
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 878
Nutri-Score and Food Perception: Insights from an Italian Study 755
On Robots and Insurance 573
A cost-effectiveness analysis for total knee arthroplasty telerehabilitation: proof of concept of a decision model 572
PDTA per la Chirurgia bariatrica: l'esperienza di sei centri italiani 516
A new organizational integrated home-care model: An Italian pilot study 505
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 503
The Effect of using Serifs in Brand Names on Luxury Perception 498
The impact of cardiovascular disease and type 2 diabetes mellitus on social cost in chronic kidney disease patients in Italy 451
How deregulation shapes market structure and industry efficiency. The case of the Italian motor insurance industry 448
Economic evaluation of da Vinci-assisted robotic surgery:a systematic review 437
A budget impact analysis (BIA) of the use of paracalcitol for the treatment of a secondary hyperparathyroidism (SHPT) in end stage renal disease patients 401
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 400
La logistica sanitaria nelle Aziende Sanitarie e Ospedaliere del Servizio Sanitario Nazionale 397
Acceptability of robotic technology in neuro-rehabilitation: Preliminary results on chronic stroke patients 390
Early Stage Economic Evaluation of Caretoy System for Early Intervention In Preterm Infants At Risk of Neurodevelopmental Disorders 383
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 374
Cost-effectiveness (CE) of imaging-guided strategies for the diagnosis of coronary artery disease (CAD): results from the EVINCI study 372
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 371
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 363
Marketing per la Sanità. Logiche e strumenti 345
Early assessment of neuro-rehabilitation technology: a case study 344
Comparative health technology assessment of robotic-assisted, direct manual laparoscopic and open surgery: a prospective study 338
Budget impact analysis of belimumab in treating Systemic Lupus Erythematosus 336
Health technology assessment. Evaluation of biomedical innovative technologies 335
A Pitcure of Private Health Insurance Policyholders in Italy 327
Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis 323
Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF 323
Scoping review and bibliometric analysis of Big Data applications for Medication adherence: An explorative methodological study to enhance consistency in literature 323
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 322
Cost analysis of the robotic surgery in Italy 320
Early assessment of neuro-rehabilitation technology 319
The opportunity of treating type II diabetes with DPP4i: an economic evaluation versus conventional treatment in the Italian setting 319
Tele-monitoring of ventilator-dependent patients: A European Respiratory Society Statement 319
How colour saturation accelerates purchase behaviour, and influences food choice: 318
Model-Based Techniques In The Early Phases of The Medical Device Development: A Systematic Literature Review 315
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 313
Early assessment of neuro – rehabilitation technology: a case study 310
A systematic literature review of the economic impact of ankylosing spondylitis 308
Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis 308
Interactive business models for Telerehabilitation after Total Knee Replacement: Preliminary results from Tuscany 306
Effectiveness and costs of different strategies for the diagnosis of stable coronary artery disease: results from the EVINCI study 305
A novel explanation of why organizations fail to adopt proven technologies: The special case of imaging in the healthcare sector 304
An economic evaluation of different procedures in bariatric surgery 303
Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies 303
Is EEG Suitable for Marketing Research? A Systematic Review 301
A new drug responding an unmet need: belimumab in the treatment of systemic lupus erythematosus 300
Social costs of different procedures in bariatric surgery in patients with obesity-related comorbidities 300
Economic evaluation of the acquisition of a remote monitoring system in the framework of a 'chronic care model' 299
Assessment of the economic impact of Belimumab for the treatment of systemic lupus erithematosus in the Italian setting: a cost-effectiveness analysis 296
Health Technology Assessment Needs Information Technology: The Experience From The First Italian Study On The Da Vinci Surgical Robot 296
Topic modeling and user network analysis on twitter during world lupus awareness day 295
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 294
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 293
Budget impact analysis of the use of extended half-life recombinant factor VIII (Efmoroctog alfa) for the treatment of congenital haemophilia A: The Italian national health system perspective 293
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 291
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 289
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 289
Analisi di budget impact sull’utilizzo di paracalcitolo nel trattamento dell’iperparatiroidismo secondario associato a malattia renale cronica 289
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 288
Economia e gestione delle imprese di assicurazione 286
The COVID-19 outbreak: From “black swan” to global challenges and opportunities 286
Innovation in rehabilitation technology: technological opportunities and socio-economic implications 284
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study 283
Natural and man-made disasters: challenges and international perspectives for insurance 282
A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools 282
Innovation in rehabilitation technology 281
Belimumab nel trattamento del Lupus Eritematoso Sistemico: valutazione di una nuova tecnologia sanitaria 281
A registry for the collection of data in cochlear implant patients 280
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 280
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 280
Economic impact of drug addiction interventions in adult population: The Peru case 278
Late chronotypes, late mealtimes. Chrononutrition and sleep habits during the COVID-19 lockdown in Italy 276
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 274
Early timing of the use of paricalcitol for the treatment of secondary hyperparathyroidism (SHPT) in chronic kidney patients (CKD): a budget impact analysis (BI) 273
Assessing the value of the use of diagnostic technology: trade offs for GPs 273
Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy? 272
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 268
Budget impact analysis of the use of extended half-life recombinant factor VIII (efmoroctocog alfa) for the treatment of congenital haemophilia a: The Italian National Health System perspective 267
Alfonso Desiata. L'Assicuratore, l'Intellettuale, la Persona 265
The quality of life of patients treated with robotic versus traditional surgery: results from an Italian observational multicenter study 265
Adherence to treatment in Behçet's syndrome: a multi-faceted issue 265
Cost-effectiveness of Different Strategies for the Diagnosis of Stable Coronary Artery Disease: Results from the Evinci Study 264
Il Governo della Sanità 263
Evidence-gathering across industry and academia on early Health Technology Assessment (HTA) of medical devices: survey design and piloting 259
Columbus' egg and the engineer's effect in forecasting solutions adoption 258
Allocazione delle Risorse al Sistema della Ricerca e Competitività del Sistema delle Imprese: una Chiave di Lettura 258
Dentro, attraverso, oltre la crisi: il caso El.En 258
PADLOck: Thefts of medicines and Hospital Pharmacies' safety. An Italian study 258
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 258
The Impact of Robotic Technology on Neuro-Rehabilitation: Preliminary Results on Acceptability And Effectiveness 257
Post-traumatic stress disorder and post-traumatic stress symptoms in patients with systemic autoimmune diseases during the COVID-19 pandemic 256
Totale 46.849
Categoria #
all - tutte 429.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 429.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021988 0 0 0 0 0 0 0 0 0 0 0 988
2021/20224.643 151 871 157 297 95 95 609 997 311 480 146 434
2022/20234.347 366 365 139 759 552 736 28 338 645 99 185 135
2023/20242.071 230 107 335 92 70 271 220 115 79 75 132 345
2024/202513.881 160 164 856 465 537 1.088 2.179 3.849 1.179 566 1.896 942
2025/202651.387 1.956 5.594 4.216 4.334 4.131 2.434 4.581 1.615 16.823 2.381 1.648 1.674
Totale 100.426